Publication date: 9 October 2014
Author(s): The Controlled Release Alliance of Dow Pharma & Food Solutions
All4NutraNo products in the cart.
All4NutraStartseite » News » DOW-COLORCON Alliance will commercialize next-generation HPMC excipient by year-end to help lower tablet manufacturing costs by up to 60 percent
Publication date: 9 October 2014
Author(s): The Controlled Release Alliance of Dow Pharma & Food Solutions
Copyright: PharmaExcipients AG